Literature DB >> 952866

Reinvestigation of some physicochemical and chemical properties of human ceruloplasmin (ferroxidase).

L Rydén, I Björk.   

Abstract

The original molecular weight determinations and hydrodynamic data on ceruloplasmin have later been contradicted by crystallographic and other investigations. In order to arrive at the correct copper stoichiometry of the protein we have undertaken a careful reinvestigation of some aspects of the physical chemistry and chemistry of ceruloplasmin with particular attention directed towards molecular weight and copper content. Human ceruloplasmin form I (the major form) was isoalted from fresh normal or retroplacental serum by a procedure designed to avoid proteolysis. The molecular weight of the protein, determined by meniscus depletion sedimentation equilibrium, was found to be 134 000+/-3 000. The sedimentation coefficient (7.25 S) and diffusion coefficient (4.46 10(-7) cm2/s) are consistent with this molecular weight. The frictional ratio calculated from these data, 1.41, and the observed intrinsic viscosity of 4.5 ml/g indicate that ceruloplasmin has a slightly more extended shape than a typical globular protein. This might at least partly be ascribed to its carbohydrate moiety. The amino acid composition, carbohydrate composition, and copper content of ceruloplasmin were determined. The copper content of several preparations varied between 6.0 and 6.6 atoms per mol. The copper stoichiometry of ceruloplasmin is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 952866     DOI: 10.1021/bi00661a003

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  Chemical evidence that proteolytic cleavage causes the heterogeneity present in human ceruloplasmin preparations.

Authors:  I B Kingston; B L Kingston; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

2.  On the mechanism of citrate inhibition of ceruloplasmin ferroxidase activity.

Authors:  R A Løvstad
Journal:  Biometals       Date:  1996-07       Impact factor: 2.949

3.  Identification of citrate as the albumin-bound inhibitor of the ferroxidase activity of ceruloplasmin.

Authors:  J Witwicki; M V Chidambaram; E Frieden
Journal:  Biol Trace Elem Res       Date:  1983-04       Impact factor: 3.738

4.  Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin.

Authors:  W H Kane; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Coordination environment and fluoride binding of type 2 copper in the blue copper oxidase ceruloplasmin.

Authors:  J H Dawson; D M Dooley; H B Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

6.  Effects of oxidative stress on some physiochemical properties of caeruloplasmin.

Authors:  P G Winyard; R C Hider; S Brailsford; A F Drake; J Lunec; D R Blake
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

7.  New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.

Authors:  G F Chowrimootoo; H A Ahmed; C A Seymour
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

8.  Pulse-radiolysis studies on the interaction of one-electron reduced species with blue oxidases. Reduction of type-2-copper-depleted ascorbate oxidase.

Authors:  P O'Neill; E M Fielden; L Avigliano; G Marcozzi; A Ballini; F Agrò
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

9.  Intact human ceruloplasmin oxidatively modifies low density lipoprotein.

Authors:  E Ehrenwald; G M Chisolm; P L Fox
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

10.  Sheep ceruloplasmin: isolation and characterization.

Authors:  L Calabrese; E Capuozzo; A Galtieri; E Bellocco
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.